Glyconex Inc (4168 TT)

GlycoNex Inc. owns complete R&D facilities including SPF animal room, cell culture room and glyco analysis equipment. The Company's main business is the development and authorization of monoclonal anti bodies and other services on carbohydrate antigen and protein drugs.